Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPS with Carbidopa and Entacapone for NOH
NCT00547911Phase 2Terminated
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Oct 2007
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH), sponsored by National Institute of Neurological Disorders and Stroke. Started Oct 2007; status: terminated.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00547911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547911.